Abbott to Pay $53M in Infant Formula Lawsuit

Key Verdict Details

A Chicago jury has ordered Abbott Laboratories to pay $53 million in compensatory damages. The verdict follows a trial where four families alleged the company failed to adequately warn that its cow’s milk-based formula for premature infants could cause necrotizing enterocolitis, or NEC, a severe intestinal disease. The jury is scheduled to deliberate on punitive damages separately.

Overview of the Situation

This case is one of hundreds of lawsuits against Abbott, maker of Similac, and Mead Johnson, maker of Enfamil, concerning their specialized formulas for preterm infants used in hospital settings. NEC is a serious condition that primarily affects premature babies and has a significant mortality rate. Abbott has consistently denied that its products cause the disease, stating that the absence of breast milk is the primary risk factor.

Economic and Legal Impact

The verdict represents a significant financial and legal challenge for Abbott. It follows a series of mixed outcomes in similar trials, including a $60 million verdict against Mead Johnson in a separate case. With nearly 1,000 lawsuits pending nationwide, the ongoing litigation poses a substantial risk to both companies, potentially impacting stock performance and future product availability as legal costs and potential payouts accumulate.

Conclusion

The $53 million ruling against Abbott underscores the escalating legal pressure on infant formula manufacturers. The market will be closely watching the decision on punitive damages and the outcomes of the numerous other pending cases, which will further clarify the financial liabilities and reputational impact on the companies involved.

FAQ

Q: What is necrotizing enterocolitis NEC?
A: It is a serious intestinal disease primarily affecting premature newborns, where bowel tissue becomes inflamed and dies.

Q: What was the total amount Abbott was ordered to pay?
A: The jury ordered $53 million in compensatory damages; a decision on additional punitive damages is still pending.

Source: Investing.com